We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$376B
AUM Growth
+$31.2B
Cap. Flow
+$4.77B
Cap. Flow %
1.27%
Top 10 Hldgs %
18.71%
Holding
8,046
New
552
Increased
3,617
Reduced
2,728
Closed
449

Sector Composition

Rank Sector Weight
1 Financials 20.82%
2 Technology 13.21%
3 Healthcare 7.99%
4 Communication Services 7.93%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCT
6351
Creative Media & Community Trust
CMCT
$14.4M
0
DALI icon
6352
First Trust DorseyWright DALI 1 ETF
DALI
$101M
$25K ﹤0.01%
1,000
DRD
6353
DRDGold
DRD
$2.1B
$25K ﹤0.01%
2,278
-5,349
-70% -$59.5K
DYAI icon
6354
Dyadic International
DYAI
$28.1M
$25K ﹤0.01%
6,969
+3,051
+78% +$12.8K
HBIO icon
6355
Harvard Bioscience
HBIO
$30.4M
$25K ﹤0.01%
302
+7
+2% +$495
KALA icon
6356
KALA BIO
KALA
$17.4M
$25K ﹤0.01%
2
PETS icon
6357
PUT
PetMed Express
PETS
$39.8M
$25K ﹤0.01%
+800
New +$25.4K
STGW icon
6358
Stagwell
STGW
$2.27B
$25K ﹤0.01%
+4,297
New +$20.1K
TNXP icon
6359
Tonix Pharmaceuticals
TNXP
$209M
0
STLN
6360
Starling Oncology, Inc. Common Stock
STLN
$666M
$25K ﹤0.01%
2,500
VYGR icon
6361
Voyager Therapeutics
VYGR
$197M
$25K ﹤0.01%
5,937
+3,660
+161% +$16.6K
WULF icon
6362
TeraWulf
WULF
$8.26B
$25K ﹤0.01%
1,300
EIGR
6363
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$25K ﹤0.01%
98
-11
-10% -$2.75K
CASA
6364
DELISTED
Casa Systems, Inc. Common Stock
CASA
$25K ﹤0.01%
2,771
+82
+3% +$727
HMPT
6365
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$25K ﹤0.01%
4,235
+3,398
+406% +$26.1K
HUGS
6366
DELISTED
USHG Acquisition Corp.
HUGS
$25K ﹤0.01%
+2,545
New +$24.9K
OACB.U
6367
DELISTED
Oaktree Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fourth of
OACB.U
$25K ﹤0.01%
2,414
APR
6368
DELISTED
Apria, Inc. Common Stock
APR
$25K ﹤0.01%
872
+78
+10% +$2.29K
HZAC
6369
DELISTED
Horizon Acquisition Corporation
HZAC
$25K ﹤0.01%
2,500
-12,000
-83% -$120K
ADME icon
6370
Aptus Behavioral Momentum ETF
ADME
$308M
$24K ﹤0.01%
600
AUBN icon
6371
Auburn National Bancorp
AUBN
$91.6M
$24K ﹤0.01%
698
+255
+58% +$9.37K
CLIR icon
6372
ClearSign Technologies
CLIR
$29.6M
$24K ﹤0.01%
500
+300
+150% +$14.2K
HERZ
6373
Herzfeld Credit Income Fund
HERZ
$32.4M
$24K ﹤0.01%
485
CUE icon
6374
Cue Biopharma
CUE
$139M
$24K ﹤0.01%
68
-6
-8% -$2.33K
LDTC
6375
DELISTED
LeddarTech
LDTC
$24K ﹤0.01%
5,000

Similar funds

Royal Bank of Canada's Q2 2021 Portfolio in Review

As of Q2 2021, Royal Bank of Canada held 8,046 positions worth $376B, up 9.1% from $345B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q2 2021 filing shows 552 new, 3,617 increased, 2,728 reduced and 449 closed positions. Its largest new stake was Coinbase: 130,336 shares worth $33M. The largest sale was GSK, an estimated $296M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q2 2021 buy was Coinbase: 130,336 shares worth $33M.
  • Royal Bank of Canada added most to Philip Morris in Q2 2021, an estimated $1.04B increase.
  • Royal Bank of Canada's biggest Q2 2021 reduction was GSK, cutting an estimated $296M.
  • Royal Bank of Canada fully exited RealPage, Inc. in Q2 2021, selling an estimated $95.4M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $376B portfolio in Q2 2021.
  • Royal Bank of Canada opened 552 new positions and closed 449 in Q2 2021.
  • Royal Bank of Canada's portfolio value rose 9.1% quarter-over-quarter to $376B.

Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.